Healthcare provider profile · identity verified

Charles A Ball, M.D.

Family Practice · COLUMBIA, TN · NPI 1154344836

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	981	91
Atorvastatin Calcium	Atorvastatin Calcium	851	115
Gabapentin	Gabapentin	499	37
Omeprazole	Omeprazole	494	61
Potassium Chloride	Potassium Chloride	411	56
Amlodipine Besylate	Amlodipine Besylate	337	55
Allopurinol	Allopurinol	299	21
Levothyroxine Sodium	Levothyroxine Sodium	293	58
Metoprolol Tartrate	Metoprolol Tartrate	247	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	236	22
Lisinopril	Lisinopril	232	45
Eliquis	Apixaban	230	42
Clopidogrel	Clopidogrel Bisulfate	218	41
Donepezil Hcl	Donepezil Hcl	218	19
Metoprolol Succinate	Metoprolol Succinate	214	25
Tamsulosin Hcl	Tamsulosin Hcl	202	30
Sertraline Hcl	Sertraline Hcl	191	29
Losartan Potassium	Losartan Potassium	187	36
Memantine Hcl	Memantine Hcl	157	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	148	21
Tramadol Hcl	Tramadol Hcl	138	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	125	suppressed
Xarelto	Rivaroxaban	123	suppressed
Trazodone Hcl	Trazodone Hcl	121	31
Carvedilol	Carvedilol	113	26
Ondansetron Hcl	Ondansetron Hcl	113	41
Divalproex Sodium	Divalproex Sodium	109	13
Levetiracetam	Levetiracetam	106	16
Metformin Hcl	Metformin Hcl	106	21
Sucralfate	Sucralfate	102	18
Methenamine Hippurate	Methenamine Hippurate	95	suppressed
Diazepam	Diazepam	91	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	90	12
Fluoxetine Hcl	Fluoxetine Hcl	89	14
Mirtazapine	Mirtazapine	86	26
Lantus	Insulin Glargine,hum.Rec.Anlog	78	suppressed
Hydralazine Hcl	Hydralazine Hcl	77	15
Oxcarbazepine	Oxcarbazepine	76	suppressed
Simvastatin	Simvastatin	76	13
Prednisone	Prednisone	75	13
Meloxicam	Meloxicam	73	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	71	70
Leflunomide	Leflunomide	71	suppressed
Januvia	Sitagliptin Phosphate	67	11
Tizanidine Hcl	Tizanidine Hcl	67	suppressed
Alendronate Sodium	Alendronate Sodium	65	11
Baclofen	Baclofen	65	suppressed
Finasteride	Finasteride	64	12
Tradjenta	Linagliptin	63	suppressed
Enulose	Lactulose	61	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	59	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	suppressed
Olanzapine	Olanzapine	55	suppressed
Lubiprostone	Lubiprostone	54	suppressed
Ropinirole Hcl	Ropinirole Hcl	54	suppressed
Insulin Lispro	Insulin Lispro	53	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	52	20
Sulfasalazine	Sulfasalazine	52	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	49	11
Nifedipine Er	Nifedipine	49	suppressed
Oxycodone Hcl	Oxycodone Hcl	49	suppressed
Famotidine	Famotidine	48	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	25
Trulicity	Dulaglutide	47	suppressed
Buspirone Hcl	Buspirone Hcl	46	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	23
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Fentanyl	Fentanyl	45	suppressed
Metolazone	Metolazone	45	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	45	13
Latanoprost	Latanoprost	44	suppressed
Bumetanide	Bumetanide	43	suppressed
Alprazolam	Alprazolam	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	41	suppressed
Glipizide	Glipizide	41	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	41	suppressed
Labetalol Hcl	Labetalol Hcl	40	suppressed
Pregabalin	Pregabalin	38	suppressed
Clonidine Hcl	Clonidine Hcl	36	11
Ibuprofen	Ibuprofen	36	suppressed
Spironolactone	Spironolactone	36	15
Ertapenem	Ertapenem Sodium	35	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Albuterol Sulfate	Albuterol Sulfate	33	13
Albuterol Sulfate Hfa	Albuterol Sulfate	33	22
Triamcinolone Acetonide	Triamcinolone Acetonide	33	15
Azithromycin	Azithromycin	32	12
Lorazepam	Lorazepam	32	18
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Cholestyramine	Cholestyramine (With Sugar)	30	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	30	suppressed
Movantik	Naloxegol Oxalate	30	suppressed
Silodosin	Silodosin	30	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Colchicine	Colchicine	28	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Lactulose	Lactulose	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	15
Chlorthalidone	Chlorthalidone	25	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	11
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	24	suppressed
Solifenacin Succinate	Solifenacin Succinate	24	suppressed
Diltiazem Hcl	Diltiazem Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	11
Isosorbide Mononitrate	Isosorbide Mononitrate	22	suppressed
Levofloxacin	Levofloxacin	22	14
Sevelamer Carbonate	Sevelamer Carbonate	22	suppressed
Cephalexin	Cephalexin	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Morphine Sulfate	Morphine Sulfate	20	suppressed
Topiramate	Topiramate	20	suppressed
Donepezil Hcl Odt	Donepezil Hcl	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	11
Hydroxyurea	Hydroxyurea	16	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Atenolol	Atenolol	14	suppressed
Nystatin	Nystatin	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	suppressed
Mexiletine Hcl	Mexiletine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Gemtesa	Vibegron	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Ozempic	Semaglutide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error